Ibex Breast Demonstrates High Accuracy, Efficiency in Study
A new peer-reviewed study confirms that Ibex Breast significantly enhances accuracy, speed, and efficiency of breast pathology evaluations.
Read MorePosted by Chris Wolski | May 6, 2025 | Breast |
A new peer-reviewed study confirms that Ibex Breast significantly enhances accuracy, speed, and efficiency of breast pathology evaluations.
Read MorePosted by Chris Wolski | May 5, 2025 | Lung Cancer |
Roche’s VENTANA TROP2 RxDx Device, a computational companion diagnostic, has received FDA Breakthrough Device Designation.
Read MorePosted by Chris Wolski | May 1, 2025 | Cardiovascular |
A major new study shows that measuring two specific lipoprotein markers provides a more accurate assessment of heart disease risk.
Read MorePosted by Chris Wolski | Apr 30, 2025 | Unknown Origin & Other Cancer Types |
Mursla Bio has received FDA Breakthrough Device Designation for EvoLiver, a novel blood test using Dynamic Biopsy technology.
Read MorePosted by Chris Wolski | Apr 29, 2025 | Molecular Diagnostics |
Karius, Inc. has launched Karius Focus | BAL, a rapid microbial cell-free DNA test that improves pathogen detection in lung infections.
Read More